Post-marketing safety assessment of constipation drugs: a real-world pharmacovigilance study based on FAERS database

The adverse reactions of constipation drugs were mainly gastrointestinal symptoms such as diarrhea, abdominal pain and abdominal distension. Linaclotide has the highest safety, and more studies are needed to analyze the cardiovascular safety of lubiprostone.